Page last updated: 2024-08-17

levodopa and CDN1163

levodopa has been researched along with CDN1163 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dahl, R	1

Other Studies

1 other study(ies) available for levodopa and CDN1163

Article	Year
A new target for Parkinson's disease: Small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned rats. Bioorganic & medicinal chemistry, 2017, 01-01, Volume: 25, Issue:1 Topics: Aminoquinolines; Animals; Benzamides; Calcium; Cell Death; Drug Discovery; Dyskinesias; Endoplasmic Reticulum Stress; Enzyme Activators; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases	2017

Article

Year

A new target for Parkinson's disease: Small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned rats.

Bioorganic & medicinal chemistry, 2017, 01-01, Volume: 25, Issue:1

Topics: Aminoquinolines; Animals; Benzamides; Calcium; Cell Death; Drug Discovery; Dyskinesias; Endoplasmic Reticulum Stress; Enzyme Activators; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2017